HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents.

Abstract
The migration, adhesion, and subsequent extravasation of leukocytes into inflamed tissues contribute to the pathogenesis of a variety of inflammatory diseases including asthma, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. The integrin adhesion receptor alpha 4 beta 1 expressed on leukocytes binds to the extracellular matrix protein fibronectin and to the cytokine inducible vascular cell adhesion molecule-1 (VCAM-1) at inflamed sites. Binding of alpha 4 beta 1 to VCAM-1 initiates firm adhesion of the leukocyte to the vascular endothelium followed by extravasation into the tissue. Monoclonal antibodies generated against either alpha 4 beta 1 or VCAM-1 can moderate this inflammatory response in a variety of animal models. Recently peptides containing a consensus LDV sequence based on the connecting segment-1 (CS-1) of fibronectin and cyclic peptides containing an RCD motif have shown promise in modulating leukocyte migration and inflammation presumably by blocking the interaction of alpha 4 beta 1 with VCAM-1. Here we describe novel, highly potent, cyclic peptides that competitively inhibit alpha 4 beta 1 binding to VCAM-1 and fibronectin at sub nanomolar concentrations. The structure of a representative analog was determined via NMR spectroscopy and used to facilitate optimization of peptide leads. The peptides discussed here utilize similar functional groups as the binding epitope of VCAM-1, inhibit lymphocyte migration in vivo, and are highly selective for alpha 4 beta 1. Furthermore the structure--activity relationships described here have provided a template for the structure-based design of small molecule antagonists of alpha 4 beta 1-mediated cell adhesion processes.
AuthorsD Y Jackson, C Quan, D R Artis, T Rawson, B Blackburn, M Struble, G Fitzgerald, K Chan, S Mullins, J P Burnier, W J Fairbrother, K Clark, M Berisini, H Chui, M Renz, S Jones, S Fong
JournalJournal of medicinal chemistry (J Med Chem) Vol. 40 Issue 21 Pg. 3359-68 (Oct 10 1997) ISSN: 0022-2623 [Print] United States
PMID9341911 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Integrin alpha4beta1
  • Integrins
  • Peptides, Cyclic
  • Receptors, Lymphocyte Homing
  • Vascular Cell Adhesion Molecule-1
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (chemical synthesis, chemistry, metabolism, pharmacology)
  • Antibodies, Monoclonal (immunology)
  • Binding, Competitive
  • Cell Adhesion (drug effects)
  • Cell Movement (drug effects)
  • Integrin alpha4beta1
  • Integrins (antagonists & inhibitors, immunology, metabolism)
  • Lymphocytes (drug effects, physiology)
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Mice
  • Models, Molecular
  • Molecular Structure
  • Peptides, Cyclic (chemical synthesis, chemistry, metabolism, pharmacology)
  • Receptors, Lymphocyte Homing (antagonists & inhibitors, immunology, metabolism)
  • Structure-Activity Relationship
  • Vascular Cell Adhesion Molecule-1 (chemistry, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: